Day: May 7, 2024

شركة Exodus Movement, Inc. تُعلن ترقية إدراجها في بورصة نيويورك للأوراق المالية بالولايات المتحدة الأمريكية

أوماها، نبراسكا،, May 07, 2024 (GLOBE NEWSWIRE) — أعلنت اليوم شركة Exodus Movement, Inc.‎ (المدرجة في سوق تداول الأوراق المالية OTCQX تحت الرمز: EXOD) (والمشار إليها فيما يلي بلفظ “Exodus” أو “الشركة”)، عن الموافقة على إدراج أسهمها العادية في بورصة نيويورك للأوراق المالية بالولايات المتحدة الأمريكية. وسوف يبدأ تداول أسهم الشركة العادية من الفئة أ بقيمة اسمية ‎$0.000001 (“الأسهم العادية”)

Read More

Hitachi Energy supports long-term operation of largest HVDC-connected wind energy project in U.S.

Multi-year agreement provides service solutions to the SunZia Transmission Project, linking New Mexico’s wind farms to Arizona’s grid, increasing renewable energy to Western States Zurich, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) — Hitachi Energy announced that it has signed a multi-year agreement with Pattern Energy to support its high-voltage direct current (HVDC) technologies for the […]

Read More

Anaqua Unveils PATTSY WAVE Version 8 IP Management Software

New release empowers IP professionals with enhanced operational efficiency and functionality BOSTON, May 07, 2024 (GLOBE NEWSWIRE) — Anaqua, the leading provider of innovation and intellectual property (IP) management technology, today announces the launch of PATTSY WAVE Version 8, the latest release of the patent and trademark management software. With this announcement, PATTSY WAVE Version 8 offers a […]

Read More

Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs

Financing led by SR One, NEA, Norwest Venture Partners, and Delos Capital with significant participation from Enavate Sciences, Longitude Capital, and other new and existing investors Proceeds to support ongoing mid- to late-stage clinical development programs for Company’s lead I&I product candidate, obexelimab WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, a global […]

Read More

Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs

Financing led by SR One, NEA, Norwest Venture Partners, and Delos Capital with significant participation from Enavate Sciences, Longitude Capital, and other new and existing investors Proceeds to support ongoing mid- to late-stage clinical development programs for Company’s lead I&I product candidate, obexelimab WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, a global […]

Read More

The World’s Wealthiest Cities in 2024

LONDON, May 07, 2024 (GLOBE NEWSWIRE) — When it comes to the number of resident millionaires with liquid investable wealth of USD 1 million or more, the US leads the pack, with 11 cities in the Top 50, including New York City, which holds firmly onto 1st place in the 2024 World’s Wealthiest Cities Report, published annually […]

Read More

The World’s Wealthiest Cities in 2024

LONDON, May 07, 2024 (GLOBE NEWSWIRE) — When it comes to the number of resident millionaires with liquid investable wealth of USD 1 million or more, the US leads the pack, with 11 cities in the Top 50, including New York City, which holds firmly onto 1st place in the 2024 World’s Wealthiest Cities Report, published annually […]

Read More

The World’s Wealthiest Cities in 2024

LONDON, May 07, 2024 (GLOBE NEWSWIRE) — When it comes to the number of resident millionaires with liquid investable wealth of USD 1 million or more, the US leads the pack, with 11 cities in the Top 50, including New York City, which holds firmly onto 1st place in the 2024 World’s Wealthiest Cities Report, published annually […]

Read More